Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Achaogen, Inc. (AKAO) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Achaogen, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1301501.
Total stock buying since 2016: $120,616,318.
Total stock sales since 2016: $2,734,942.
Total stock option exercises since 2016: $1,070,704.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 0 | $0 | 3,640,697 | $2,115,990 | 0 | $0 |
| 2018 | 3,714,812 | $31,808,835 | 20,748 | $195,815 | 177,935 | $941,276 |
| 2017 | 95,012 | $1,057,483 | 19,742 | $385,713 | 35,363 | $129,428 |
| 2016 | 6,500,000 | $87,750,000 | 10,045 | $37,424 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-03 | 0 | $0 | 3,631,895 | $2,107,782 | 0 | $0 |
| 2019-02 | 0 | $0 | 8,802 | $8,208 | 0 | $0 |
| 2018-12 | 765,779 | $1,234,437 | 0 | $0 | 0 | $0 |
| 2018-11 | 393,903 | $736,105 | 0 | $0 | 0 | $0 |
| 2018-09 | 0 | $0 | 4,280 | $17,761 | 0 | $0 |
| 2018-06 | 0 | $0 | 5,097 | $53,802 | 177,935 | $941,276 |
| 2018-05 | 976,880 | $11,166,715 | 0 | $0 | 0 | $0 |
| 2018-04 | 789,894 | $10,245,006 | 0 | $0 | 0 | $0 |
| 2018-03 | 693,356 | $7,364,200 | 2,735 | $32,108 | 0 | $0 |
| 2018-02 | 30,000 | $323,522 | 8,636 | $92,144 | 0 | $0 |
| 2018-01 | 65,000 | $738,850 | 0 | $0 | 0 | $0 |
| 2017-12 | 95,012 | $1,057,483 | 0 | $0 | 0 | $0 |
| 2017-09 | 0 | $0 | 5,622 | $89,895 | 0 | $0 |
| 2017-08 | 0 | $0 | 0 | $0 | 35,363 | $129,428 |
| 2017-06 | 0 | $0 | 2,066 | $44,480 | 0 | $0 |
| 2017-03 | 0 | $0 | 3,079 | $81,839 | 0 | $0 |
| 2017-02 | 0 | $0 | 3,161 | $71,942 | 0 | $0 |
| 2017-01 | 0 | $0 | 5,814 | $97,557 | 0 | $0 |
| 2016-12 | 6,500,000 | $87,750,000 | 0 | $0 | 0 | $0 |
| 2016-09 | 0 | $0 | 4,701 | $20,218 | 0 | $0 |
| 2016-03 | 0 | $0 | 5,344 | $17,206 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-20 | Duggan Robert W | Sale | 50,000 | .53 | 26,500 |
| 2019-03-19 | Duggan Robert W | Sale | 956,009 | .53 | 506,684 |
| 2019-03-18 | Duggan Robert W | Sale | 271,879 | .56 | 152,252 |
| 2019-03-13 | Duggan Robert W | Sale | 1,199,930 | .59 | 707,958 |
| 2019-03-12 | Duggan Robert W | Sale | 633,975 | .61 | 386,724 |
| 2019-03-11 | Duggan Robert W | Sale | 520,102 | .63 | 327,664 |
| 2019-02-21 | Bhatt Elizabeth (Chief Operating Officer) | Sale | 971 | .89 | 864 |
| 2019-02-21 | Dorling Janet (Chief Commercial Officer) | Sale | 1,063 | .89 | 946 |
| 2019-02-21 | Sarpangal Zeryn (Chief Financial Officer) | Sale | 1,388 | .89 | 1,235 |
| 2019-02-21 | Wise Blake (Chief Executive Officer) | Sale | 3,771 | .89 | 3,356 |
| 2019-02-21 | Loeb Gary (See Remarks) | Sale | 791 | .89 | 703 |
| 2019-02-05 | Dorling Janet (Chief Commercial Officer) | Sale | 818 | 1.35 | 1,104 |
| 2018-12-11 | Duggan Robert W | Buy | 306,848 | 1.65 | 505,071 |
| 2018-12-10 | Duggan Robert W | Buy | 436,500 | 1.60 | 697,963 |
| 2018-12-07 | Duggan Robert W | Buy | 22,431 | 1.40 | 31,403 |
| 2018-11-27 | Duggan Robert W | Buy | 77,585 | 1.68 | 129,954 |
| 2018-11-23 | Duggan Robert W | Buy | 80,175 | 1.89 | 151,610 |
| 2018-11-20 | Duggan Robert W | Buy | 231,495 | 1.93 | 447,016 |
| 2018-11-19 | Duggan Robert W | Buy | 4,648 | 1.62 | 7,525 |
| 2018-09-25 | Wise Blake (Chief Operating Officer) | Sale | 3,242 | 4.15 | 13,454 |
| 2018-09-25 | Loeb Gary (General Counsel) | Sale | 1,038 | 4.15 | 4,307 |
| 2018-06-28 | Hillan Kenneth J. (See Remarks) | Option Ex | 177,935 | 5.29 | 941,276 |
| 2018-06-26 | Dorling Janet (Chief Commercial Officer) | Sale | 450 | 9.59 | 4,315 |
| 2018-06-26 | Schilke Tobin (Chief Financial Officer) | Sale | 298 | 9.59 | 2,857 |
| 2018-06-26 | Wise Blake (Chief Executive Officer) | Sale | 1,194 | 9.59 | 11,450 |
| 2018-06-26 | Hillan Kenneth J. (See Remarks) | Sale | 744 | 9.59 | 7,134 |
| 2018-06-26 | Loeb Gary (General Counsel) | Sale | 324 | 9.59 | 3,107 |
| 2018-06-11 | Schilke Tobin (Chief Financial Officer) | Sale | 2,087 | 11.95 | 24,939 |
| 2018-05-03 | Duggan Robert W | Buy | 976,880 | 11.43 | 11,166,715 |
| 2018-04-27 | Duggan Robert W | Buy | 102,849 | 12.96 | 1,333,128 |
| 2018-04-26 | Duggan Robert W | Buy | 50,000 | 12.96 | 647,750 |
| 2018-04-25 | Duggan Robert W | Buy | 77,247 | 13.02 | 1,005,987 |
| 2018-04-23 | Duggan Robert W | Buy | 132,487 | 13.06 | 1,730,942 |
| 2018-04-20 | Duggan Robert W | Buy | 216,150 | 13.23 | 2,860,529 |
| 2018-04-19 | Duggan Robert W | Buy | 119,700 | 12.76 | 1,527,252 |
| 2018-04-04 | Duggan Robert W | Buy | 47,361 | 12.44 | 588,981 |
| 2018-04-03 | Duggan Robert W | Buy | 24,100 | 12.46 | 300,237 |
| 2018-04-02 | Duggan Robert W | Buy | 20,000 | 12.51 | 250,200 |
| 2018-03-28 | Duggan Robert W | Buy | 30,000 | 12.44 | 373,110 |
| 2018-03-20 | Duggan Robert W | Buy | 25,000 | 11.09 | 277,150 |
| 2018-03-19 | Duggan Robert W | Buy | 11,300 | 11.20 | 126,559 |
| 2018-03-15 | Duggan Robert W | Buy | 30,000 | 11.22 | 336,750 |
| 2018-03-14 | Duggan Robert W | Buy | 19,660 | 11.57 | 227,485 |
| 2018-03-13 | Hillan Kenneth J. (See Remarks) | Sale | 2,735 | 11.74 | 32,108 |
| 2018-03-12 | Duggan Robert W | Buy | 20,000 | 11.39 | 227,800 |
| 2018-03-09 | Duggan Robert W | Buy | 50,000 | 11.41 | 570,500 |
| 2018-03-02 | Duggan Robert W | Buy | 96,790 | 10.14 | 981,644 |
| 2018-03-01 | Duggan Robert W | Buy | 410,606 | 10.33 | 4,243,202 |
| 2018-02-28 | Duggan Robert W | Buy | 20,000 | 10.70 | 213,920 |
| 2018-02-21 | Swem Lee (Chief Scientific Officer) | Sale | 1,282 | 10.67 | 13,678 |
| 2018-02-21 | Schilke Tobin (Chief Financial Officer) | Sale | 1,108 | 10.67 | 11,822 |
| 2018-02-21 | Wise Blake (Chief Executive Officer) | Sale | 1,640 | 10.67 | 17,498 |
| 2018-02-21 | Hillan Kenneth J. (See Remarks) | Sale | 4,606 | 10.67 | 49,146 |
| 2018-02-14 | Duggan Robert W | Buy | 9,442 | 10.96 | 103,484 |
| 2018-02-13 | Duggan Robert W | Buy | 558 | 10.96 | 6,118 |
| 2018-01-05 | Duggan Robert W | Buy | 50,000 | 11.51 | 575,500 |
| 2018-01-03 | Duggan Robert W | Buy | 15,000 | 10.89 | 163,350 |
| 2017-12-18 | Duggan Robert W | Buy | 95,012 | 11.13 | 1,057,483 |
| 2017-09-26 | Wise Blake (President & COO) | Sale | 3,576 | 15.99 | 57,180 |
| 2017-09-26 | Loeb Gary (General Counsel) | Sale | 1,146 | 15.99 | 18,324 |
| 2017-09-25 | Swem Lee (Chief Scientific Officer) | Sale | 900 | 15.99 | 14,391 |
| 2017-08-23 | Wise Blake (President & COO) | Option Ex | 35,363 | 3.66 | 129,428 |
| 2017-06-12 | Schilke Tobin (Chief Financial Officer) | Sale | 2,066 | 21.53 | 44,480 |
| 2017-03-14 | Hillan Kenneth J. (Chief Executive Officer) | Sale | 3,079 | 26.58 | 81,839 |
| 2017-02-21 | Sarpangal Zeryn (See Remarks) | Sale | 439 | 22.76 | 9,991 |
| 2017-02-21 | Friedland Ian (SVP, Chief Medical Officer) | Sale | 1,026 | 22.76 | 23,351 |
| 2017-02-21 | Hillan Kenneth J. (Chief Executive Officer) | Sale | 1,696 | 22.76 | 38,600 |
| 2017-01-26 | Schilke Tobin (Chief Financial Officer) | Sale | 955 | 16.78 | 16,024 |
| 2017-01-26 | Sarpangal Zeryn (VP, HR and Corporate Affairs) | Sale | 781 | 16.78 | 13,105 |
| 2017-01-26 | Wise Blake (Chief Operating Officer) | Sale | 1,431 | 16.78 | 24,012 |
| 2017-01-26 | Friedland Ian (Chief Medical Officer) | Sale | 695 | 16.78 | 11,662 |
| 2017-01-26 | Hillan Kenneth J. (Chief Executive Officer) | Sale | 1,431 | 16.78 | 24,012 |
| 2017-01-26 | Loeb Gary (General Counsel) | Sale | 521 | 16.78 | 8,742 |
| 2016-12-19 | Nea 15 Gp, Llc (10% Owner) | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-12-19 | Sakoda Jon (10% Owner) | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-12-19 | Florence Anthony A. Jr. (10% Owner) | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-12-19 | Sonsini Peter W. (10% Owner) | Buy | 1,000,000 | 13.50 | 13,500,000 |
| 2016-12-19 | Viswanathan Ravi (10% Owner) | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-12-19 | Baskett Forest (10% Owner) | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-12-19 | Kolluri Krishna Kittu (10% Owner) | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-12-19 | Sandell Scott D (10% Owner) | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-12-19 | Makower Joshua (10% Owner) | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-12-19 | Mott David M (10% Owner) | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-12-19 | Barris Peter J (10% Owner) | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-09-27 | Sarpangal Zeryn (VP, HR and Corporate Affairs) | Sale | 1,069 | 4.30 | 4,597 |
| 2016-09-27 | Wise Blake (Chief Operating Officer) | Sale | 3,632 | 4.30 | 15,621 |
| 2016-03-17 | Friedland Ian (Chief Medical Officer) | Sale | 1,772 | 3.22 | 5,705 |
| 2016-03-17 | Hillan Kenneth J. (Chief Executive Officer) | Sale | 3,572 | 3.22 | 11,501 |
Insider trading activities including stock purchases, stock sales, and option exercises of AKAO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Achaogen, Inc. (symbol AKAO, CIK number 1301501) see the Securities and Exchange Commission (SEC) website.